• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的药理学模型

Pharmacologic models of Alzheimer's disease.

作者信息

Patel S, Tariot P N

机构信息

University of Rochester School of Medicine, New York.

出版信息

Psychiatr Clin North Am. 1991 Jun;14(2):287-308.

PMID:2062722
Abstract

The disruption of multiple neurotransmitter systems in Alzheimer's disease plays an important role in the pathophysiology of cognitive and behavioral disturbances associated with the illness. The central cholinergic system is significantly disrupted in a fashion that correlates with cognitive impairment. This article describes drugs, such as scopolamine, that selectively affect the cholinergic system and model aspects of Alzheimer's disease phenomenology in both animals and humans. Drugs that induce cognitive changes but whose chemical mechanisms are not well understood are presented as alternative pharmacologic models of Alzheimer's disease.

摘要

阿尔茨海默病中多种神经递质系统的紊乱在与该疾病相关的认知和行为障碍的病理生理学中起着重要作用。中枢胆碱能系统以与认知障碍相关的方式受到显著破坏。本文介绍了东莨菪碱等药物,这些药物选择性地影响胆碱能系统,并在动物和人类中模拟阿尔茨海默病现象学的各个方面。还介绍了能引起认知变化但其化学机制尚不清楚的药物,作为阿尔茨海默病的替代药理学模型。

相似文献

1
Pharmacologic models of Alzheimer's disease.阿尔茨海默病的药理学模型
Psychiatr Clin North Am. 1991 Jun;14(2):287-308.
2
The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
Psychiatr Clin North Am. 1991 Jun;14(2):461-82.
3
[Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease].
Cesk Psychiatr. 1987 Feb;83(1):36-45.
4
[Animal model for Alzheimer's disease based on the blockade of neuronal nicotinic acetylcholine receptors].基于神经元烟碱型乙酰胆碱受体阻断的阿尔茨海默病动物模型
Wei Sheng Yan Jiu. 1999 Jul;28(4):218-20.
5
The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease.p75神经营养因子受体在阿尔茨海默病胆碱能功能障碍中的作用
Neuroscientist. 2009 Aug;15(4):317-23. doi: 10.1177/1073858408331376. Epub 2009 May 20.
6
Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
N Engl J Med. 1985 Jul 4;313(1):7-11. doi: 10.1056/NEJM198507043130102.
7
Alzheimer's disease: cognitive and behavioral pharmacotherapy.阿尔茨海默病:认知与行为的药物治疗
Conn Med. 1997 Sep;61(9):543-52.
8
[Neurotransmitters in Alzheimer's disease].[阿尔茨海默病中的神经递质]
Rev Neurol. 2006;42(6):350-3.
9
Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.胆碱能-5-羟色胺能失衡导致阿尔茨海默病的认知和行为症状。
Neuropsychologia. 2005;43(3):442-9. doi: 10.1016/j.neuropsychologia.2004.06.007.
10
Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.两种APP过表达小鼠模型中枢神经系统中胆碱能标志物、生物胺和氨基酸的分析
Neurochem Int. 2005 Apr;46(5):409-22. doi: 10.1016/j.neuint.2004.11.005. Epub 2005 Jan 17.

引用本文的文献

1
Neuroprotective and Antiamnesic Effects of Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice.野生茜草科植物对东莨菪碱诱导的小鼠记忆损伤的神经保护及抗遗忘作用
Behav Neurol. 2017;2017:5952897. doi: 10.1155/2017/5952897. Epub 2017 Mar 12.
2
Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.啮齿动物 5C-CPT 的反向翻译表明,精神分裂症患者的注意力受损与东莨菪碱诱导的小鼠缺陷相似。
Transl Psychiatry. 2013 Nov 12;3(11):e324. doi: 10.1038/tp.2013.82.
3
Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism.
神经激肽 3 受体作为预测和改善老年机体学习记忆的靶点。
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15097-102. doi: 10.1073/pnas.1306884110. Epub 2013 Aug 27.
4
NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.NMDA 神经传递功能障碍与阿尔茨海默病的行为和心理症状。
Curr Neuropharmacol. 2012 Sep;10(3):272-85. doi: 10.2174/157015912803217288.
5
Age-related decline in central cholinergic function demonstrated with scopolamine.东莨菪碱显示与年龄相关的中枢胆碱能功能衰退。
Psychopharmacology (Berl). 1996 May;125(1):50-6. doi: 10.1007/BF02247392.